As the potential of GLP-1 agonists for addiction gains traction, big pharma is also starting to take notice, namely the two ...

It’s hard to turn on the TV these days without seeing ads for drugs like Ozempic, Wegovy, Zepbound or Mounjaro. These ...

Eating Patterns in America” report highlighted the growing year-over-year trend toward at-home dining, with 86% of eating ...

For kidney transplant recipients with type 2 diabetes, use of glucagon-like peptide-1 receptor agonists was associated with ...

ANAHEIM, CALIF. — Evolving consumer need states combined with unpredictable economic factors are changing the way snack manufacturers interact with customers today, according to a panel of snack ...

From singing on Broadway to playing beloved characters on the big screen (including everyone's favorite animated snowman, ...

GLP-1 therapy is a groundbreaking approach in the treatment of obesity and metabolic health issues. GLP-1, or glucagon-like ...

NotCo announced Thursday the launch of its GLP Booster, a product that can be mixed into any food to naturally help you feel ...

Kennedy Jr., who was tapped to lead the Department of Health and Human Services for the Trump administration, recently ...

Roche & Zealand join forces on petrelintide, advancing obesity treatments with innovative amylin analogs. Find out why this ...

Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...